Abstract:Understanding the intricate relationship between cancer clinicopathological features and anesthetics dosage is crucial for optimizing patient outcomes and safety during surgery. This retrospective study investigates this relationship in patients with non-small cell lung cancer (NSCLC) undergoing video-assisted thoracic surgery (VATS). A comprehensive analysis of medical records was undertaken for NSCLC patients who underwent VATS with intravenous compound inhalation general anesthesia. Patients were categorized based on histological, chemotherapy, radiotherapy, and epidural anesthesia factors. Statistical analysis was performed to compare the differences between the groups. The results revealed compelling insights. Specifically, patients with lung adenocarcinoma (LUAD) undergoing VATS exhibited higher dosages of rocuronium bromide and midazolam during general anesthesia, coupled with a shorter post-anesthesia care unit (PACU) stay compared to those with squamous cell carcinoma (sqCL). Furthermore, chemotherapy patients undergoing VATS demonstrated diminished requirements for phenylephrine and remifentanil in contrast to their non-chemotherapy counterparts. Similarly, radiotherapy patients undergoing VATS demonstrated a decreased necessity for rocuronium bromide compared to non-radiotherapy patients. Notably, patients who received epidural anesthesia in combination with general anesthesia manifested reduced hydromorphone requirements and prolonged hospital stays compared to those subjected to general anesthesia alone. In conclusion, the findings from this study indicate several important observations in diverse patient groups undergoing VATS. The higher dosages of rocuronium bromide and midazolam in LUAD patients point to potential differences in drug requirements among varying lung cancer types. Additionally, the observed shorter PACU stay in LUAD patients suggests a potentially expedited recovery process. The reduced anesthetic requirements of phenylephrine and remifentanilin chemotherapy patients indicate distinct responses to anesthesia and pain management. Radiotherapy patients requiring lower doses of rocuronium bromide imply a potential impact of prior radiotherapy on muscle relaxation. Finally, the combination of epidural anesthesia with general anesthesia resulted in reduced hydromorphone requirements and longer hospital stays, suggesting the potential benefits of this combined approach in terms of pain management and postoperative recovery. These findings highlight the importance of tailoring anesthesia strategies for specific patient populations to optimize outcomes in VATS procedures.

Volatile Anesthetics Regulate Anti-Cancer Relevant Signaling

Progress in the Research of Relationship between Anesthesia and Inflammatory Regulation

An In Silico Investigation of the Molecular Interactions between Volatile Anesthetics and Actin

Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia

Effect of Inhalation Anesthetics on Tumor Metastasis

Inhaled volatile anesthetics in the intensive care unit

Application of Anesthetics in Cancer Patients: Reviewing Current Existing Link With Tumor Recurrence

Systemic immune effects of anesthetics and their intracellular targets in tumors

Optimizing anesthesia strategies to NSCLC patients in VATS procedures: Insights from drug requirements and patient recovery patterns

The potential anti-tumor effect of anesthetics on cancer by regulating autophagy

Volatile anesthetics for lung- and diaphragm-protective sedation

Anesthetic Techniques and Cancer Outcomes: What Is the Current Evidence?

Research advances in the roles of local anesthetics in tumor metastasis and recurrence

Association Between Anesthesia Delivered During Tumor Resection and Cancer Survival: a Systematic Review of a Mixed Picture with Constant Themes

Anesthesia, surgical stress, and "long-term" outcomes

Effect of Volatile Anesthesia Versus Intravenous Anesthesia on Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy: A Randomized Clinical Trial

Type of anesthesia for cancer resection surgery: No differential impact on cancer recurrence in mouse models of breast cancer

Anesthesia and Cancer: Something More than Avoiding Stress Response

Outcomes of Intravenous and Inhalation Anesthesia on Patients Undergoing Esophageal Cancer Surgery: a Retrospective Observational Study

Total intravenous or inhalational volatile anaesthesia and survival after colorectal cancer surgery: a Swedish national registry study

The Potential Benefits of the Use of Regional Anesthesia in Cancer Patients